Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
FOSNETUPITANT
(2018)
Small molecule
Unknown
Unknown
Approved
Unknown
FOSNETUPITANT
×
Maximum Phase:
4
First Approval:
2018
UNII:
T672P80L2S
Molecule Type:
Small molecule
Molecular Formula:
C31H35F6N4O5P
Molecular Weight:
688.61
AlogP:
5.74
PSA:
106.03
HBD:
1.0
HBA:
#RotB:
8.0
Source:
MIGALASTAT HYDROCHLORIDE
(2018)
Small molecule
Alpha-galactosidase A stabiliser
ORAL
Approved
Fabry Disease
MIGALASTAT HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2018
UNII:
CLY7M0XD20
Molecule Type:
Small molecule
Molecular Formula:
C6H14ClNO4
Molecular Weight:
199.63
AlogP:
-2.97
PSA:
92.95
HBD:
5.0
HBA:
#RotB:
1.0
Source:
LUSUTROMBOPAG
(2018)
Small molecule
Thrombopoietin receptor agonist
ORAL
Approved
Hemorrhage; Thrombocytopenia
LUSUTROMBOPAG
×
Maximum Phase:
4
First Approval:
2018
UNII:
6LL5JFU42F
Molecule Type:
Small molecule
Molecular Formula:
C29H32Cl2N2O5S
Molecular Weight:
591.56
AlogP:
8.52
PSA:
97.75
HBD:
2.0
HBA:
#RotB:
13.0
Source:
IVOSIDENIB
(2018)
Small molecule
Isocitrate dehydrogenase [NADP] cytoplasmic inhibitor
ORAL
Approved
Leukemia, Myeloid, Acute; Neoplasms
IVOSIDENIB
×
Maximum Phase:
4
First Approval:
2018
UNII:
Q2PCN8MAM6
Molecule Type:
Small molecule
Molecular Formula:
C28H22ClF3N6O3
Molecular Weight:
582.97
AlogP:
4.32
PSA:
119.29
HBD:
1.0
HBA:
#RotB:
7.0
Source:
DUVELISIB
(2018)
Small molecule
PI3-kinase p110-delta subunit inhibitor
ORAL
Approved
Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Lymphoma, Follicular; Neoplasms
DUVELISIB
×
Maximum Phase:
4
First Approval:
2018
UNII:
610V23S0JI
Molecule Type:
Small molecule
Molecular Formula:
C22H17ClN6O
Molecular Weight:
416.87
AlogP:
4.48
PSA:
88.49
HBD:
2.0
HBA:
#RotB:
4.0
Source:
SARECYCLINE HYDROCHLORIDE
(2018)
Small molecule
Unknown
ORAL
Approved
Acne Vulgaris; Infections
SARECYCLINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2018
UNII:
36718856JR
Molecule Type:
Small molecule
Molecular Formula:
C24H30ClN3O8
Molecular Weight:
523.97
AlogP:
0.11
PSA:
173.86
HBD:
5.0
HBA:
#RotB:
5.0
Source:
PRUCALOPRIDE
(2018)
Small molecule
Serotonin 4 (5-HT4) receptor agonist
Unknown
Approved
Constipation
PRUCALOPRIDE
×
Maximum Phase:
4
First Approval:
2018
UNII:
0A09IUW5TP
Molecule Type:
Small molecule
Molecular Formula:
C18H26ClN3O3
Molecular Weight:
367.88
AlogP:
2.09
PSA:
76.82
HBD:
2.0
HBA:
#RotB:
6.0
Source:
TEZACAFTOR
(2018)
Small molecule
Cystic fibrosis transmembrane conductance regulator positive modulator
Unknown
Approved
Cystic Fibrosis
TEZACAFTOR
×
Maximum Phase:
4
First Approval:
2018
UNII:
8RW88Y506K
Molecule Type:
Small molecule
Molecular Formula:
C26H27F3N2O6
Molecular Weight:
520.5
AlogP:
3.4
PSA:
113.18
HBD:
4.0
HBA:
#RotB:
8.0
Source:
GLYCOPYRRONIUM TOSYLATE
(2018)
Small molecule
Unknown
TOPICAL
Approved
Arrhythmias, Cardiac; Bronchitis, Chronic; Cerebral Palsy; Hyperhidrosis; Peptic Ulcer; Pulmonary Disease, Chronic Obstructive
GLYCOPYRRONIUM TOSYLATE
×
Maximum Phase:
4
First Approval:
2018
UNII:
1PVF6JLU7B
Molecule Type:
Small molecule
Molecular Formula:
C26H37NO7S
Molecular Weight:
507.65
AlogP:
2.46
PSA:
46.53
HBD:
1.0
HBA:
#RotB:
4.0
Source:
GILTERITINIB
(2018)
Small molecule
Tyrosine-protein kinase receptor FLT3 inhibitor
Unknown
Approved
Neoplasms
GILTERITINIB
×
Maximum Phase:
4
First Approval:
2018
UNII:
66D92MGC8M
Molecule Type:
Small molecule
Molecular Formula:
C29H44N8O3
Molecular Weight:
552.72
AlogP:
2.7
PSA:
121.11
HBD:
3.0
HBA:
#RotB:
9.0
Source:
FOSTAMATINIB DISODIUM
(2018)
Small molecule
Tyrosine-protein kinase SYK inhibitor
ORAL
Approved
Purpura, Thrombocytopenic, Idiopathic; Thrombocytopenia
FOSTAMATINIB DISODIUM
×
Maximum Phase:
4
First Approval:
2018
UNII:
86EEZ49YVB
Molecule Type:
Small molecule
Molecular Formula:
C23H36FN6Na2O15P
Molecular Weight:
732.52
AlogP:
3.09
PSA:
186.72
HBD:
4.0
HBA:
#RotB:
10.0
Source:
MOXIDECTIN
(2018)
Small molecule
Unknown
ORAL
Approved
Helminthiasis; Onchocerciasis
MOXIDECTIN
×
Maximum Phase:
4
First Approval:
2018
UNII:
NGU5H31YO9
Molecule Type:
Small molecule
Molecular Formula:
C37H53NO8
Molecular Weight:
639.83
AlogP:
5.73
PSA:
116.04
HBD:
2.0
HBA:
#RotB:
3.0
Source:
FOSNETUPITANT CHLORIDE HYDROCHLORIDE
(2018)
Small molecule
Neurokinin 1 receptor antagonist
Unknown
Approved
Nausea; Vomiting
FOSNETUPITANT CHLORIDE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2018
UNII:
ZR36MFA9P8
Molecule Type:
Small molecule
Molecular Formula:
C31H37Cl2F6N4O5P
Molecular Weight:
761.53
AlogP:
5.74
PSA:
106.03
HBD:
1.0
HBA:
#RotB:
8.0
Source:
TALAZOPARIB
(2018)
Small molecule
Poly [ADP-ribose] polymerase 2 inhibitor
Unknown
Approved
Neoplasms
TALAZOPARIB
×
Maximum Phase:
4
First Approval:
2018
UNII:
9QHX048FRV
Molecule Type:
Small molecule
Molecular Formula:
C19H14F2N6O
Molecular Weight:
380.36
AlogP:
2.63
PSA:
88.49
HBD:
2.0
HBA:
#RotB:
2.0
Source:
SEGESTERONE ACETATE
(2018)
Small molecule
Progesterone receptor agonist
Unknown
Approved
Unknown
SEGESTERONE ACETATE
×
Maximum Phase:
4
First Approval:
2018
UNII:
9AMX4Q13CC
Molecule Type:
Small molecule
Molecular Formula:
C23H30O4
Molecular Weight:
370.49
AlogP:
4.19
PSA:
60.44
HBD:
0.0
HBA:
#RotB:
2.0
Source:
REVEFENACIN
(2018)
Small molecule
Muscarinic acetylcholine receptor M3 antagonist
INHALATION
Approved
Lung Diseases, Obstructive; Pulmonary Disease, Chronic Obstructive
REVEFENACIN
×
Maximum Phase:
4
First Approval:
2018
UNII:
G2AE2VE07O
Molecule Type:
Small molecule
Molecular Formula:
C35H43N5O4
Molecular Weight:
597.76
AlogP:
4.84
PSA:
108.21
HBD:
2.0
HBA:
#RotB:
10.0
Source:
ELAGOLIX
(2018)
Small molecule
Gonadotropin-releasing hormone receptor antagonist
Unknown
Approved
Unknown
ELAGOLIX
×
Maximum Phase:
4
First Approval:
2018
UNII:
5B2546MB5Z
Molecule Type:
Small molecule
Molecular Formula:
C32H30F5N3O5
Molecular Weight:
631.6
AlogP:
5.54
PSA:
102.56
HBD:
2.0
HBA:
#RotB:
12.0
Source:
LOFEXIDINE
(2018)
Small molecule
Unknown
Unknown
Approved
Substance-Related Disorders
LOFEXIDINE
×
Maximum Phase:
4
First Approval:
2018
UNII:
UI82K0T627
Molecule Type:
Small molecule
Molecular Formula:
C11H12Cl2N2O
Molecular Weight:
259.14
AlogP:
2.76
PSA:
33.62
HBD:
1.0
HBA:
#RotB:
3.0
Source:
LAROTRECTINIB
(2018)
Small molecule
Neurotrophic tyrosine kinase receptor inhibitor
Unknown
Approved
Neoplasms
LAROTRECTINIB
×
Maximum Phase:
4
First Approval:
2018
UNII:
PF9462I9HX
Molecule Type:
Small molecule
Molecular Formula:
C21H22F2N6O2
Molecular Weight:
428.44
AlogP:
2.95
PSA:
86.0
HBD:
2.0
HBA:
#RotB:
3.0
Source:
BENZHYDROCODONE HYDROCHLORIDE
(2018)
Small molecule
Opioid receptors; mu/kappa/delta agonist
Unknown
Approved
Acute Pain; Substance-Related Disorders
BENZHYDROCODONE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2018
UNII:
I894QAU7FJ
Molecule Type:
Small molecule
Molecular Formula:
C25H26ClNO4
Molecular Weight:
439.94
AlogP:
3.72
PSA:
48.0
HBD:
0.0
HBA:
#RotB:
3.0
Source:
SODIUM ZIRCONIUM CYCLOSILICATE
(2018)
Small molecule
Potassium chelating agent
ORAL
Approved
Unknown
SODIUM ZIRCONIUM CYCLOSILICATE
×
Maximum Phase:
4
First Approval:
2018
UNII:
D652ZWF066
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BALOXAVIR MARBOXIL
(2018)
Small molecule
Polymerase acidic protein inhibitor
ORAL
Approved
Influenza, Human; Virus Diseases
BALOXAVIR MARBOXIL
×
Maximum Phase:
4
First Approval:
2018
UNII:
505CXM6OHG
Molecule Type:
Small molecule
Molecular Formula:
C27H23F2N3O7S
Molecular Weight:
571.56
AlogP:
3.39
PSA:
99.54
HBD:
0.0
HBA:
#RotB:
4.0
Source:
DORAVIRINE
(2018)
Small molecule
Reverse transcriptase negative allosteric modulator
ORAL
Approved
HIV Infections; Virus Diseases
DORAVIRINE
×
Maximum Phase:
4
First Approval:
2018
UNII:
913P6LK81M
Molecule Type:
Small molecule
Molecular Formula:
C17H11ClF3N5O3
Molecular Weight:
425.75
AlogP:
2.65
PSA:
105.7
HBD:
1.0
HBA:
#RotB:
4.0
Source:
ELAGOLIX SODIUM
(2018)
Small molecule
Gonadotropin-releasing hormone receptor antagonist
ORAL
Approved
Endometriosis
ELAGOLIX SODIUM
×
Maximum Phase:
4
First Approval:
2018
UNII:
5948VUI423
Molecule Type:
Small molecule
Molecular Formula:
C32H29F5N3NaO5
Molecular Weight:
653.58
AlogP:
5.54
PSA:
102.56
HBD:
2.0
HBA:
#RotB:
12.0
Source:
GLASDEGIB
(2018)
Small molecule
Smoothened homolog antagonist
Unknown
Approved
Neoplasms
GLASDEGIB
×
Maximum Phase:
4
First Approval:
2018
UNII:
K673DMO5H9
Molecule Type:
Small molecule
Molecular Formula:
C21H22N6O
Molecular Weight:
374.45
AlogP:
3.39
PSA:
96.84
HBD:
3.0
HBA:
#RotB:
3.0
Source:
TAFENOQUINE SUCCINATE
(2018)
Small molecule
Unknown
ORAL
Approved
Malaria; Malaria, Vivax
TAFENOQUINE SUCCINATE
×
Maximum Phase:
4
First Approval:
2018
UNII:
DL5J0B8VSS
Molecule Type:
Small molecule
Molecular Formula:
C28H34F3N3O7
Molecular Weight:
581.59
AlogP:
5.91
PSA:
78.63
HBD:
2.0
HBA:
#RotB:
9.0
Source:
RIFAMYCIN
(2018)
Small molecule
Unknown
ORAL
Approved
Eye Infections; Tuberculosis
RIFAMYCIN
×
Maximum Phase:
4
First Approval:
2018
UNII:
DU69T8ZZPA
Molecule Type:
Small molecule
Molecular Formula:
C37H47NO12
Molecular Weight:
697.78
AlogP:
4.75
PSA:
201.31
HBD:
6.0
HBA:
#RotB:
2.0
Source:
AMIFAMPRIDINE PHOSPHATE
(2018)
Small molecule
Voltage-gated potassium channel blocker
ORAL
Approved
Lambert-Eaton Myasthenic Syndrome
AMIFAMPRIDINE PHOSPHATE
×
Maximum Phase:
4
First Approval:
2018
UNII:
8HF8FIN815
Molecule Type:
Small molecule
Molecular Formula:
C5H10N3O4P
Molecular Weight:
207.13
AlogP:
0.25
PSA:
64.93
HBD:
2.0
HBA:
#RotB:
0.0
Source:
DACOMITINIB
(2018)
Small molecule
Epidermal growth factor receptor erbB1 inhibitor
ORAL
Approved
Carcinoma, Non-Small-Cell Lung; Neoplasms
DACOMITINIB
×
Maximum Phase:
4
First Approval:
2018
UNII:
5092U85G58
Molecule Type:
Small molecule
Molecular Formula:
C24H25ClFN5O2
Molecular Weight:
469.95
AlogP:
5.16
PSA:
79.38
HBD:
2.0
HBA:
#RotB:
7.0
Source:
MIGALASTAT
(2018)
Small molecule
Alpha-galactosidase A stabiliser
Unknown
Approved
Unknown
MIGALASTAT
×
Maximum Phase:
4
First Approval:
2018
UNII:
C4XNY919FW
Molecule Type:
Small molecule
Molecular Formula:
C6H13NO4
Molecular Weight:
163.17
AlogP:
-2.97
PSA:
92.95
HBD:
5.0
HBA:
#RotB:
1.0
Source:
PLAZOMICIN
(2018)
Small molecule
Unknown
Unknown
Approved
Bacterial Infections
PLAZOMICIN
×
Maximum Phase:
4
First Approval:
2018
UNII:
LYO9XZ250J
Molecule Type:
Small molecule
Molecular Formula:
C25H48N6O10
Molecular Weight:
592.69
AlogP:
-5.36
PSA:
269.29
HBD:
11.0
HBA:
#RotB:
13.0
Source:
TAFENOQUINE
(2018)
Small molecule
Unknown
Unknown
Approved
Malaria
TAFENOQUINE
×
Maximum Phase:
4
First Approval:
2018
UNII:
262P8GS9L9
Molecule Type:
Small molecule
Molecular Formula:
C24H28F3N3O3
Molecular Weight:
463.5
AlogP:
5.91
PSA:
78.63
HBD:
2.0
HBA:
#RotB:
9.0
Source:
STIRIPENTOL
(2018)
Small molecule
Unknown
ORAL
Approved
Epilepsies, Myoclonic; Epilepsy; Seizures
STIRIPENTOL
×
Maximum Phase:
4
First Approval:
2018
UNII:
R02XOT8V8I
Molecule Type:
Small molecule
Molecular Formula:
C14H18O3
Molecular Weight:
234.29
AlogP:
2.84
PSA:
38.69
HBD:
1.0
HBA:
#RotB:
2.0
Source:
BARICITINIB
(2018)
Small molecule
Tyrosine-protein kinase JAK1 inhibitor
ORAL
Approved
Arthritis, Rheumatoid; Immune System Diseases
BARICITINIB
×
Maximum Phase:
4
First Approval:
2018
UNII:
ISP4442I3Y
Molecule Type:
Small molecule
Molecular Formula:
C16H17N7O2S
Molecular Weight:
371.43
AlogP:
1.1
PSA:
120.56
HBD:
1.0
HBA:
#RotB:
5.0
Source:
ERAVACYCLINE
(2018)
Small molecule
Unknown
Unknown
Approved
Bacterial Infections
ERAVACYCLINE
×
Maximum Phase:
4
First Approval:
2018
UNII:
07896928ZC
Molecule Type:
Small molecule
Molecular Formula:
C27H31FN4O8
Molecular Weight:
558.56
AlogP:
0.29
PSA:
193.73
HBD:
6.0
HBA:
#RotB:
5.0
Source:
APALUTAMIDE
(2018)
Small molecule
Androgen Receptor antagonist
ORAL
Approved
Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant
APALUTAMIDE
×
Maximum Phase:
4
First Approval:
2018
UNII:
4T36H88UA7
Molecule Type:
Small molecule
Molecular Formula:
C21H15F4N5O2S
Molecular Weight:
477.44
AlogP:
3.53
PSA:
89.33
HBD:
1.0
HBA:
#RotB:
3.0
Source:
1
2
…
68
69
70
71
72
73
74
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA